Neoadjuvant Toripalimab for Non-squamous NSCLC With EGFR Mutation

Clinical trial NCT05962021 · UNKNOWN

Trial details

NCT number: NCT05962021
Sponsor: Peking University People's Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non Squamous Non Small Cell Lung Cancer EGFR Positive Non-small Cell Lung Cancer

Start date: 2023-08-01
Primary completion: 2026-06-30
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.